Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease

被引:61
作者
Coskun, M
Bacanli, A
Sallakci, N
Alpsoy, E [1 ]
Yavuzer, U
Yegin, O
机构
[1] Akdeniz Univ, Sch Med, Dept Dermatol, TR-07070 Antalya, Turkey
[2] Akdeniz Univ, Sch Med, Dept Pediat Immunol, TR-07070 Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Physiol, TR-07070 Antalya, Turkey
关键词
Behcet's disease; gene polymorphisms; interleukin-1; alpha; beta; interleukin-1 receptor antagonist genes;
D O I
10.1111/j.0906-6705.2005.00253.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Genetic factors that predispose individuals to Behcet's disease (BD) are considered to play important roles in the development of the disease. The pro-inflammatory cytokine interleukin-1 (IL-1) has been implicated in the pathogenesis of BD. Our aim was to determine a possible association of specific polymorphisms of IL-1alpha, IL-1beta, and IL-1 receptor antagonist genes with susceptibility for BD. We genotyped 72 patients with BD and 163 healthy controls for IL-1alpha-889, IL-1beta-511, and +3953 (nt5887) single-nucleotide polymorphisms besides IL-1 receptor antagonist variable number of tandem repeat polymorphism (for five different alleles). Comparison of the IL-1beta+3953 T allele and TT genotype frequencies showed a significant difference between patients with BD and controls (54.2 vs. 40.5%, OR = 1.74, P = 0.024, and 40.3 vs. 19.6%, OR = 2.76, P = 0.009, respectively). However, no difference was observed in the genotype or allele frequencies of IL-1alpha-889, IL-1beta-511, and IL-1 receptor antagonist between the patients with BD and the controls. Our results indicate that susceptibility to BD is increased in individuals carrying the IL-1beta+3953 T allele and TT genotype.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 46 条
[1]   Mapping the HLA association in Behcet's disease - A role for tumor necrosis factor polymorphisms? [J].
Ahmad, T ;
Wallace, GR ;
James, T ;
Neville, M ;
Bunce, M ;
Mulcahy-Hawes, K ;
Armuzzi, A ;
Crawshaw, J ;
Fortune, F ;
Walton, R ;
Stanford, MR ;
Welsh, KI ;
Marshall, SE ;
Jewell, DP .
ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :807-813
[2]   Review of the chronology of clinical manifestations in 60 patients with Behcet's disease [J].
Alpsoy, E ;
Donmez, L ;
Bacanli, A ;
Apaydin, C ;
Butun, B .
DERMATOLOGY, 2003, 207 (04) :354-356
[3]   Serum of patients with Behcet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro [J].
Alpsoy, E ;
Kodelja, V ;
Goerdt, S ;
Orfanos, CE ;
Zouboulis, CC .
DERMATOLOGY, 2003, 206 (03) :225-232
[4]  
Alpsoy Erkan, 1998, Journal of Dermatology (Tokyo), V25, P158
[5]  
Alpsoy Erkan, 1998, Journal of Dermatology (Tokyo), V25, P513
[6]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[7]   IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels [J].
Buchs, N ;
di Giovine, FS ;
Silvestri, T ;
Vannier, E ;
Duff, GW ;
Miossec, P .
GENES AND IMMUNITY, 2001, 2 (04) :222-228
[8]   Periodontal findings and systemic antibody responses to oral microorganisms in Behcet's disease [J].
Çelenligil-Nazliel, H ;
Kansu, E ;
Ebersole, JL .
JOURNAL OF PERIODONTOLOGY, 1999, 70 (12) :1449-1456
[9]  
CLAY FE, 1994, HUM GENET, V94, P407
[10]  
DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303